Literature DB >> 11121118

Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains.

K Yuasa1, Y Kanoh, K Okumura, K Omori.   

Abstract

PDE11A is a dual-substrate, cAMP and cGMP, cyclic nucleotide phosphodiesterase (PDE). Presently four unique variants carrying distinct GAF sequences in the N-terminal region have been identified. While human PDE11A3 and PDE11A4 are known to be specifically expressed in testis and prostate, respectively, PDE11A1 was mainly detected in skeletal muscle. The human PDE11A gene was investigated and revealed to span > 300 kb, contain 23 exons and be mapped on chromosome 2q31. The transcription start sites of PDE11A1, PDE11A3 and PDE11A4 were determined, and the promoter sequences were revealed. Although 5' flanking genomic regions of PDE11A1 and PDE11A3 had a consensus TATA motif, that of PDE11A4 was a TATA-less but contained CCAAT box and Sp1-binding sequence. Interestingly, we found that the exon 2 sequence for N-terminal region of PDE11A3 encoded an N-terminal sequence of the cytochrome c pseudogene in an alternate reading frame, and that C-terminal region of the cytochrome c pseudogene in intron 2 was disrupted by the insertion of Alu repetitive sequence. Furthermore, we examined the exon-intron organization of the PDE2A gene and compared the exon organization among GAF-PDE family. The exon organization of the PDE11A catalytic domain was very similar to those of PDE5A and PDE6B. However, other GAF-PDEs, PDE2A and PDE10A, displayed different exon organization from PDE11A although these three PDEs are similar in their amino-acid sequences to each other. The findings suggested that PDE11A has a common ancestral gene with PDE5A and PDE6s, whereas PDE2A and PDE10A are generated separately from these three GAF-PDEs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11121118     DOI: 10.1046/j.1432-1327.2001.01866.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Activation of PDE10 and PDE11 phosphodiesterases.

Authors:  Ronald Jäger; Corina Russwurm; Frank Schwede; Hans-Gottfried Genieser; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

Review 2.  A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

Authors:  Michy P Kelly
Journal:  Adv Neurobiol       Date:  2017

3.  Determinants for phosphodiesterase 6 inhibition by its gamma-subunit.

Authors:  Zhongming Zhang; Nikolai O Artemyev
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

Review 4.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

5.  Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.

Authors:  Michele P Kelly; Sheree F Logue; Julie Brennan; Jonathon P Day; Subha Lakkaraju; Lixin Jiang; Xiaotian Zhong; May Tam; Stacey J Sukoff Rizzo; Brian J Platt; Jason M Dwyer; Sarah Neal; Virginia L Pulito; Michael J Agostino; Steven M Grauer; Rachel L Navarra; Cody Kelley; Thomas A Comery; Richard J Murrills; Miles D Houslay; Nicholas J Brandon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

6.  Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.

Authors:  Ma-Li Wong; Fiona Whelan; Panagiotis Deloukas; Pamela Whittaker; Marcos Delgado; Rita M Cantor; Samuel M McCann; Julio Licinio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

7.  Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.

Authors:  Katy Pilarzyk; Latarsha Porcher; William R Capell; Steven D Burbano; Jeff Davis; Janet L Fisher; Nicole Gorny; Siena Petrolle; Michy P Kelly
Journal:  Aging Cell       Date:  2022-09-08       Impact factor: 11.005

8.  Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.

Authors:  Tracy M Reed; David R Repaske; Gretchen L Snyder; Paul Greengard; Charles V Vorhees
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

9.  Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.

Authors:  S A Boikos; A Horvath; S Heyerdahl; E Stein; A Robinson-White; I Bossis; J Bertherat; J A Carney; C A Stratakis
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

10.  Association of PDE11A global haplotype with major depression and antidepressant drug response.

Authors:  Huai-Rong Luo; Gui-Sheng Wu; Chuanhui Dong; Mauricio Arcos-Burgos; Luciana Ribeiro; Julio Licinio; Ma-Li Wong
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.